Applied Biosystems Announces Management Changes.

FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, today announced that, effective immediately, Mark Stevenson has been appointed Division President, Molecular Biology Division, which is being renamed the Molecular and Cellular Biology Division. He succeeds William V. Murray, who has resigned for personal reasons. Other members of the senior leadership team within the Division will remain in their positions.

Also effective immediately, Leonard Klevan has been named to succeed Mark Stevenson as Division President, Applied Markets Division. The Applied Markets Division produces and markets reagent kits for DNA forensics, paternity testing and other forms of human identification as well as products for biosecurity, food/agriculture, and environmental applications.

"Mark Stevenson has done an outstanding job building and leading the Applied Markets Division, and we are very fortunate that Mark now will lead the Molecular and Cellular Biology Division," said Catherine M. Burzik, President, Applied Biosystems. "We recently hired Lenny Klevan, a proven senior-level executive, and feel he is well positioned to succeed Mark as Division President, Applied Markets. The leadership skills and business knowledge of Mark and Lenny, combined with the strong in-place teams they inherit, should enable their divisions to continue momentum and achieve success with vital initiatives."

Mr. Stevenson has been Division President, Applied Markets Division, since it was created in 2004. Prior to his current position, he was President and General Manager of Applied Biosystems Japan Ltd, responsible for directing the sales, service and support efforts in Japan. Previously, he had similar responsibility for Applied Biosystems' genomics and informatics business throughout Europe. He joined Applied Biosystems in 1998.

Dr. Klevan joined Applied Biosystems earlier this year as Vice President of R&D for Applied Markets. Prior to joining AB, he was Chief Executive Officer of ReliaGene Technologies, a forensic and paternity testing laboratory and previously he was President and CEO of MiraiBio (Hitachi Genetic Systems), a subsidiary of Hitachi Software Engineering. Earlier in his career, he managed technology acquisition and business development for Life Technologies. Dr. Klevan has a BA in Chemistry from the State University of New York and a PhD in Physical Chemistry from Yale University.

About Applera Corporation and Applied Biosystems

Applera Corporation consists of two operating groups. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems' products also serve the needs of some markets outside of life science research, which we refer to as "applied markets," such as the fields of: human identity testing (forensic and paternity testing); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, for example in food and the environment. Applied Biosystems is headquartered in Foster City, CA, and reported sales of nearly $1.8 billion during fiscal 2005. The Celera Genomics Group is focused on discovery, development, and commercialization of diagnostic products as well as leveraging its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets, and is also seeking to advance therapeutic antibody and selected small molecule drug programs in collaboration with global technology and market leaders. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800.762.6923. Information about Applied Biosystems is available at http://www.appliedbiosystems.com.

Copyright(C) 2006. Applera Corporation. All Rights Reserved. Applied Biosystems, AB (Design), and Celera are registered trademarks, and Applera, Celera Diagnostics, and Celera Genomics are trademarks of Applera Corporation or its subsidiaries in the U. S. and/or certain other countries.